NANOTECHNOLOGY DEVELOPMENTS AGAINST SARS-COV-2: CURRENT FACTS AND NEW OPPORTUNITIES

被引：0

作者：

Petrov, Petar D. ^{[1
]}

机构：

[1] Bulgarian Acad Sci, Inst Polymers, Akad G Bonchev St,Bl 103A, Sofia 1113, Bulgaria

来源：

COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES | 2021年 / 74卷 / 05期

关键词：

COVID-19; SARS-CoV-2; nanotechnology; nanovaccines; nanomaterials; NEUTRALIZING ANTIBODIES; SPIKE PROTEIN; NANOPARTICLES; IMMUNIZATION; VIRUS;

D O I：

10.7546/CRABS.2021.05.01

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Coronavirus infectious disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affected all major aspects of society worldwide. Therefore, it is imperative to expedite the development of highly effective tools for reducing person-to-person virus transmission, effective treatment of patients and disease prevention. Huge efforts are being made on how to adapt the existing knowledge and speed up the transfer of our developments to help society tackle this global problem. In this regard, nanotechnology has offered vast opportunities to boost the fabrication of frontline tools against SARS-CoV-2. This review article discusses the advancement of nanotechnology in fabricating nanovaccines and antiviral nanoformulations, nanomaterial-based diagnostic platforms and personal protective equipment (PPE) for the fight with the new coronavirus.

引用

页码：631 / 648

页数：18

共 59 条

[1] Nanoparticle-Based Vaccines Against Respiratory Viruses [J].

Al-Halifa, Soultan ;

Gauthier, Laurie ;

Arpin, Dominic ;

Bourgault, Steve ;

Archambault, Denis .

FRONTIERS IN IMMUNOLOGY, 2019, 10

[2] The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis [J].

Alphandery, Edouard .

BIOCONJUGATE CHEMISTRY, 2020, 31 (08) :1873-1882

[3] Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults [J].

Anderson, E. J. ;

Rouphael, N. G. ;

Widge, A. T. ;

Jackson, L. A. ;

Roberts, P. C. ;

Makhene, M. ;

Chappell, J. D. ;

Denison, M. R. ;

Stevens, L. J. ;

Pruijssers, A. J. ;

McDermott, A. B. ;

Flach, B. ;

Lin, B. C. ;

Doria-Rose, N. A. ;

O'Dell, S. ;

Schmidt, S. D. ;

Corbett, K. S. ;

Swanson, P. A., II ;

Padilla, M. ;

Neuzil, K. M. ;

Bennett, H. ;

Leav, B. ;

Makowski, M. ;

Albert, J. ;

Cross, K. ;

Edara, V. V. ;

Floyd, K. ;

Suthar, M. S. ;

Martinez, D. R. ;

Baric, R. ;

Buchanan, W. ;

Luke, C. J. ;

Phadke, V. K. ;

Rostad, C. A. ;

Ledgerwood, J. E. ;

Graham, B. S. ;

Beigel, J. H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) :2427-2438

[4]

[Anonymous], COVID 19 DASHBOARD C

[5]

[Anonymous], 2021, NANOFIBER MASKS NEW

[6]

[Anonymous], CORONAVIRUS NANOTECH

[7]

[Anonymous], 2021, LIPOSOMES LIPID NANO

[8] Virucidal effect against coronavirus SARS-CoV-2 of a silver nanocluster/ silica composite sputtered coating [J].

Balagna, Cristina ;

Perero, Sergio ;

Percivalle, Elena ;

Nepita, Edoardo Vecchio ;

Ferraris, Monica .

OPEN CERAMICS, 2020, 1

[9]

Basak Soumyadeep, 2020, Nano-Structures & Nano-Objects, V24, P101, DOI 10.1016/j.nanoso.2020.100620

[10] Nanomaterial Delivery Systems for mRNA Vaccines [J].

Buschmann, Michael D. ;

Carrasco, Manuel J. ;

Alishetty, Suman ;

Paige, Mikell ;

Alameh, Mohamad Gabriel ;

Weissman, Drew .

VACCINES, 2021, 9 (01) :1-30

← 1 2 3 4 5 6 →